Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 76% of retail investor accounts lose money when trading spread bets and CFDs with this provider. You should consider whether you understand how spread bets and CFDs work, and whether you can afford to take the high risk of losing your money.
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 76% of retail investor accounts lose money when trading spread bets and CFDs with this provider. You should consider whether you understand how spread bets and CFDs work, and whether you can afford to take the high risk of losing your money.

Could the Rentokil share price look cheap a year from now?

The Rentokil share price soared to a record 636p in November. While overpaying for rival Terminix has seen it fall to 570p for now, this proposed new entity will be the largest pest control company in the world.

The Rentokil (LON: RTO) share price has been volatile over the past few days. This isn’t normal for a FTSE 100 stock, much less one that specialises in the essential, but prosaic world of pest control.

The company has been enjoying a stellar run over the past two years. In line with the rest of the FTSE 100, it fell 29% from 508p on 21 February 2020 to 362p on 27 March 2020. While the rest of the index has yet to completely recover from the mini-crash, Rentokil’s share price soared to a record high of 636p by 12 November 2021, as pandemic-driven demand for its hygiene services rocketed.

The stock then dropped slightly, to 624p by the morning of 14 December. Then Rentokil announced a takeover deal with competitor Terminix. While the initial reaction saw its share price rise, by the end of the next trading day, it had fallen 16% to 522p.

However, it was the top FTSE 100 riser yesterday, recovering to 570p. But it’s clear some investors were not happy with the detail of the proposed merger.

Rentokil share price: Terminix takeover

Rentokil has agreed to buy Terminix for $6.7 billion. And encouragingly, this is no hostile takeover, as both boards have approved the deal. 643 million new Rentokil shares will be created and handed over to Terminix shareholders, along with $1.3 billion in hard cash.

The scale of the deal spooked some investors — as it values Terminix shares at $55 apiece, a 47% premium over Terminix’s closing price on 13 December, and a 32.5% premium over its previous 90-day volume-weighted average. Moreover, Terminix shareholders will own 26% of the merged company.

But if the deal gains regulatory and shareholder approval, it will allow Rentokil to massively expand its business in the key North America region, which represents 51% of the global pest control market. Furthermore, the new company will be the largest pest control services company in the world, with 56,000 employees and a five million-strong customer base.

In its regulatory filing, Rentokil said that North America has a ‘fragmented market comprising over 20,000 pest control companies.’ There is a significant opportunity for the new entity to use its ‘complementary and synergistic combination’ to grow market share in the lucrative $11 billion region.

And in October’s Q3 results, Rentokil said that ‘our pest control business in North America continued to demonstrate very strong momentum, growing revenues by 24.6%’ despite ‘some (pandemic-caused) labour shortages.’

The future of pest control?

Rentokil Chairman Richard Solomons and Terminix CEO Andy Ransom will retain their roles in the combined group. Solomons commented that it ‘will have a highly talented and experienced management team able to more effectively create value and enhance long-term growth.’ And Ransom argues that the deal ‘will create the global leader in commercial, residential and termite pest control.’ He further believes that they are ‘two highly complementary businesses,’ and that ‘this is a win-win-win for colleagues, customers and shareholders.’

According to both companies, the global pest control market has an estimated 2020 worth of around $22 billion and is ‘estimated to grow at between 4.5% and 5%+ over the medium term.’ Analysts at Peel Hunt hailed the deal as a ‘transformational acquisition.’

Meanwhile, the Omicron variant of coronavirus is starting to chill the spines of leaders worldwide. In the US, White House Chief Medical Adviser Anthony Fauci believes that ‘it is quite likely that we are going to see in some sections of the country a significant stress on the hospital system.’

And in a press conference yesterday, PM Boris Johnson told the public that ‘we are looking at all kinds of things to keep Omicron under control, and we will rule nothing out.’ With travel and social restrictions being reimposed across Europe, Rentokil’s services will remain in strong demand.

In Q3, ongoing revenue, excluding disinfection services, grew by 14.5% to £750.2 million. And the companies expect to generate at least $150 million in cost savings within three years of merger completion.

And while the Rentokil share price has dipped slightly, it’s up 158% over the past five years. And a year from now, it plans to be the global market leader. Of course, the best laid plans of mice and men often go awry…

Go short and long with spread bets, CFDs and share dealing on 16,000+ shares with the UK’s No.1 platform.* Learn more about trading shares with us, or open an account to get started today.

* Best trading platform as awarded at the ADVFN International Financial Awards 2021

This information has been prepared by IG, a trading name of IG Markets Limited. In addition to the disclaimer below, the material on this page does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. IG accepts no responsibility for any use that may be made of these comments and for any consequences that result. No representation or warranty is given as to the accuracy or completeness of this information. Consequently any person acting on it does so entirely at their own risk. Any research provided does not have regard to the specific investment objectives, financial situation and needs of any specific person who may receive it. It has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication. Although we are not specifically constrained from dealing ahead of our recommendations we do not seek to take advantage of them before they are provided to our clients. See full non-independent research disclaimer and quarterly summary.

Act on share opportunities today

Go long or short on thousands of international stocks with spread bets and CFDs.

  • Get full exposure for a comparatively small deposit
  • Trade on spreads from just 0.1%
  • Get greater order book visibility with direct market access

See opportunity on a stock?

Try a risk-free trade in your demo account, and see whether you’re on to something.

  • Log in to your demo
  • Take your position
  • See whether your hunch pays off

See opportunity on a stock?

Don’t miss your chance – upgrade to a live account to take advantage.

  • Trade a huge range of popular stocks
  • Analyse and deal seamlessly on fast, intuitive charts
  • See and react to breaking news in-platform

See opportunity on a stock?

Don’t miss your chance. Log in to take advantage while conditions prevail.

Live prices on most popular markets

  • Equities
  • Indices
  • Forex
  • Commodities
website terms and agreements. Prices are indicative only. All share prices are delayed by at least 15 minutes.

" edit-mode="false"> liveprices.javascriptrequired


Prices above are subject to our website terms and agreements. Prices are indicative only. All share prices are delayed by at least 15 minutes.

liveprices.javascriptrequired
liveprices.javascriptrequired
liveprices.javascriptrequired

Prices above are subject to our website terms and agreements. Prices are indicative only. All shares prices are delayed by at least 15 mins.

Plan your trading week

Get the week’s market-moving news sent directly to your inbox every Sunday. The Week Ahead gives you a full calendar of upcoming economic events, as well as commentary from our expert analysts on the key markets to watch.


For more info on how we might use your data, see our privacy notice and access policy and privacy webpage.

You might be interested in…

Find out what charges your trades could incur with our transparent fee structure.

Discover why so many clients choose us, and what makes us a world-leading provider of spread betting and CFDs.

Stay on top of upcoming market-moving events with our customisable economic calendar.